Patents by Inventor Elma R. Fernandes
Elma R. Fernandes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20040214759Abstract: In methods of using a fibroblast growth factor, such as for treating, preventing or delaying a proliferation-associated disorder, steps are provided to administer to a subject a therapeutically effective amount of a particular fibroblast growth factor polypeptide, or variant or fragment thereof.Type: ApplicationFiled: May 9, 2003Publication date: October 28, 2004Inventors: John P. Alsobrook, Enrique Alvarez, David W. Anderson, Joel S. Bader, Ferenc L. Boldog, Catherine E. Burgess, Rajeev A. Chillakuru, Lisa Deegler, Shlomit R. Edinger, Elma R. Fernandes, Linda Gorman, William M. Grosse, John L. Herrmann, Michael E. Jeffers, William J. LaRochelle, Denise M. Lepley, Henri S. Lichenstein, Kumar Namdev, Muralidhara Padigaru, Carol E. A. Pena, Sudhirdas K. Prayaga, Daniel K. Rieger, Richard A. Shimkets, Pascal Valax, Meijia Yang, Zachary Yim, Mei Zhong
-
Publication number: 20040043382Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases.Type: ApplicationFiled: March 7, 2002Publication date: March 4, 2004Inventors: Muralidhara Padigaru, Kimberly A. Spytek, Suresh G. Shenoy, Raymond J. Taupier, Carol E. A. Pena, Li Li, Bryan D. Zerhusen, Vladimir Y. Gusev, Weizhen Ji, Linda Gorman, Charles E. Miller, Ramesh Kekuda, Meera Patturajan, Esha A. Gangolli, Corine A.M. Vernet, Xiaojia Sasha Guo, Velizar T. Tchernev, Elma R. Fernandes, Stacie J. Casman, Uriel M. Malyankar, Valerie Gerlach, Yi Liu, David W. Anderson, Steven K. Spaderna, Elina Catterton, Mario W. Leite, Haihong Zhong, John P. Alsobrook, Denise M. Lepley, Daniel K. Rieger, Catherine E. Burgess
-
Publication number: 20040029220Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: June 18, 2002Publication date: February 12, 2004Inventors: Corine A.M. Vernet, Elma R. Fernandes, Valerie Gerlach, Richard A. Shimkets, Uriel M. Malyankar, Ferenc L. Boldog, Bryan D. Zerhusen, Kimberly A. Spytek, Kumud Majumder, Velizar T. Tchernev, Muralidhara Padigaru, Meera Patturajan, Catherine E. Burgess, Esha A. Gangolli, Glennda Smithson, Luca Rastelli, John R. MacDougall, Raymond J. Taupier, William M. Grosse, Edward S. Szekeres, John P. Alsobrook, David W. Anderson, Xiaojia (Sasha) Guo, Li Li, Mei Zhong
-
Publication number: 20040014173Abstract: The present invention provides novel polypeptides, termed SECX polypeptides, as well as polynucleotides encoding SECX polypeptides and antibodies that immunospecifically bind to SECX or a derivative, variant, mutant, or fragment of the SECX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the SECX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to others uses.Type: ApplicationFiled: March 10, 2003Publication date: January 22, 2004Inventors: David W. Anderson, Ferenc L. Boldog, Stacie J. Casman, Shlomit R. Edinger, Karen Ellerman, Elma R. Fernandes, Erik Gunther, Martin D. Leach, John R. MacDougall, Muralidhara Padigaru, Richard A. Shimkets, Glennda Smithson, Kimberly A. Spytek
-
Publication number: 20040006015Abstract: The present invention is based upon methods of treating inflammatory conditions in the intestinal tract of mammals using growth factor related polypeptides. The invention includes methods of reducing the mortality rate or delaying mortality in a subject suffering from an inflammatory pathology. Methods of using fibroblast growth factor-CX (FGF-CX) polynucleotides sequences and the FGF-CX polypeptides encoded by such nucleic acid sequence, or variants, fragments and homologs thereof, are claimed in the invention. Similarly, methods of using FCTRX polynucleotide sequences and the FCTRX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, alone or in combination, are also claimed in the invention. FCTRX collectively refers to any of six variant FCTRX sequences, variously designated FCTR1, FCTR2, FCTR3, FCTR4, FCTR5 and FCTR6.Type: ApplicationFiled: December 16, 2002Publication date: January 8, 2004Inventors: Ferenc L. Boldog, Catherine E. Burgess, Elma R. Fernandes, Michael E. Jeffers, William J. LaRochelle, Henri S. Lichenstein, Jeffrey Peterson, Sudhirdas K. Prayaga, Beth Rittman, Juliette B. Shimkets, Richard A. Shimkets, Meijia Yang
-
Publication number: 20040002134Abstract: This application is drawn to novel nucleic acid sequences encoding mammalian polypeptides that have sequence similarity to human KIAA0768 protein and human protein PRO228. The nucleic acid sequence is 2862 nucleotides long and contains an open reading frame from nucleotides 508-510 to 2557-9. The novel, encoded polypeptides comprise 683 amino acid residues.Type: ApplicationFiled: October 15, 2001Publication date: January 1, 2004Applicant: CuraGen CorporationInventors: Richard A. Shimkets, Elma R. Fernandes, John L. Herrman, Corine A.M. Vernet
-
Publication number: 20040002120Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: March 7, 2002Publication date: January 1, 2004Inventors: Ramesh Kekuda, Velizar T. Tchernev, Xiaohong Liu, Kimberly A. Spytek, Meera Patturajan, Catherine E. Burgess, Corine A.M. Vernet, Li Li, Linda Gorman, Uriel M. Malyankar, Ferenc L. Boldog, Xiaojia (Sasha) Guo, Suresh G. Shenoy, Muralidhara Padigaru, Raymond J. Taupier, Charles E. Miller, Stacie J. Casman, Carol E. A. Pena, Esha A. Gangolli, Vladimir Y. Gusev, Glennda Smithson, Bryan D. Zerhusen, Valerie Gerlach, Pascale F-J Pochart, Elma R. Fernandes, Richard A. Shimkets, Luca Rastelli, Steven K. Spaderna, William J. LaRochelle, Mei Zhong, Nikolai V. Khramtsov, Edward Z. Voss, John L. Herrmann
-
Publication number: 20030212256Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: October 16, 2001Publication date: November 13, 2003Inventors: Shlomit R. Edinger, Valerie Gerlach, John R. MacDougall, Uriel M. Malyankar, Glennda Smithson, Isabelle Millet, John A. Peyman, David J. Stone, Erik Gunther, Karen Ellerman, Richard A. Shimkets, Muralidhara Padigaru, Xiaojia Guo, Meera Patturajan, Raymond J. Taupier, Catherine E. Burgess, Bryan D. Zerhusen, Ramesh Kekuda, Kimberly A. Spytek, Esha A. Gangolli, Elma R. Fernandes, Linda Gorman
-
Publication number: 20030207348Abstract: The invention provides polypeptides, designated herein as SECP polypeptides, as well as polynucleotides encoding SECP polypeptides, and antibodies that immunospecifically-bind to SECP polypeptide or polynucleotide, or derivatives, variants, mutants, or fragments thereof. The invention additionally provides methods in which the SECP polypeptide, polynucleotide, and antibody are used in the detection, prevention, and treatment of a broad range of pathological states.Type: ApplicationFiled: February 13, 2002Publication date: November 6, 2003Inventors: Richard A. Shimkets, Elma R. Fernandes, Li Li, Linda Gorman, Vladimir Y. Gusev, Muralidhara Padigaru, Meera Patturajan, Suresh G. Shenoy, Kimberly A. Spytek
-
Publication number: 20030170630Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: December 21, 2001Publication date: September 11, 2003Inventors: John P. Alsobrook, Velizar T. Tchernev, Xiaohong Liu, Kimberly A. Spytek, Bryan D. Zerhusen, Meera Patturajan, Denise M. Lepley, Catherine E. Burgess, Richard A. Shimkets, William M. Grosse, Edward S. Szekeres, Corine A.M. Vernet, Li Li, Stacie J. Casman, Ference L. Boldog, Linda Gorman, Esha A. Gangolli, Elma R. Fernandes, Danier K. Rieger, Shlomit R. Edinger, Erik Gunther, Isabelle Millet, Paul Sciore, Karen Ellerman, John R. MacDougall, Glennda Smithson
-
Publication number: 20030165829Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: February 27, 2001Publication date: September 4, 2003Inventors: Muralidhara Padigaru, Kumud Majumder, Catherine E. Burgess, Corine A.M. Vernet, Elma R. Fernandes, Richard A. Shimkets, Velizar T. Tchernev, Vishnu Mishra, Stacie Casman, Kimberly A. Spytek, Bryan D. Zerhusen
-
Publication number: 20030153495Abstract: The present invention is based upon methods of treating inflammatory conditions in the intestinal tract of mammals using growth factor related polypeptides. The invention includes methods of reducing the morality rate or delaying mortality in a subject suffering from an inflammatory pathology. Methods of using fibroblast growth factor-CX (FGF-CX) polynucleotide sequences and the FGF-CX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, are claimed in the invention. Similarly, methods of using FCTRX polynucleotide sequences and the FCTRX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, alone or in combination, are also claimed in the invention. FCTRX collectively refers to any of six variant FCTRX sequences, variously designated FCTR1, FCTR2, FCTR3, FCTR4, FCTR5 and FCTR6.Type: ApplicationFiled: November 16, 2001Publication date: August 14, 2003Inventors: Henry S. Lichenstein, Michael E. Jeffers, Richard A. Shimkets, Sudhirdas K. Prayaga, Ferenc L. Boldog, Meijia Yang, Catherine E. Burgess, Elma R. Fernandes, Beth Rittman, Juliette B. Shimkets, William J. LaRochelle
-
Publication number: 20030129613Abstract: The present invention provides novel isolated SECX polynucleotides and the membrane-associated or secreted polypeptides encoded by the SECX polynucleotides. Also provided are the antibodies that immunospecifically bind to a SECX polypeptide or any derivative, variant, mutant or fragment of the SECX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the SECX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.Type: ApplicationFiled: July 3, 2002Publication date: July 10, 2003Inventors: Elma R. Fernandes, Corine A.M. Vernet, Richard A. Shimkets, David W. Anderson, Muralidhara Padigaru, Ferenc L. Boldog, Li Li, Suresh G. Shenoy, Stacie J. Casman, Luca Rastelli
-
Publication number: 20030083244Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: April 25, 2001Publication date: May 1, 2003Inventors: Corine A.M. Vernet, Elma R. Fernandes, Valerie Gerlach, Richard A. Shimkets, Uriel M. Malyankar, Ferenc L. Boldog, Bryan D. Zerhusen, Kimberly A. Spytek, Kumud Majumder, Velizar T. Tchernev, Muralidhara Padigaru, Meera Patturajan, Catherine E. Burgess, Esha A. Gangolli, Glennda Smithson, Luca Rastelli, John R. MacDougall, Raymond J. Taupier, William M. Grosse, Edward S. Szekeres, John P. Alsobrook
-
Publication number: 20030077697Abstract: The present invention provides a novel isolated SER5 polynucleotide and a polypeptide encoded by the SER5 polynucleotide. Also provided are the antibodies that immunospecifically bind to a SER5 polypeptide or any derivative, variant, mutant or fragment of the SER5 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the SER5 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states as well as other uses.Type: ApplicationFiled: July 3, 2001Publication date: April 24, 2003Inventors: Valerie L. Gerlach, John R. MacDougall, Kerry E. Quinn, Kumud Majumder, Kimberly A. Spytek, Corine Vernet, Catherine E. Burgess, Elma R. Fernandes, Luca Rastelli, John L. Herrmann, Steven K. Spaderna, Richard A. Shimkets, Raymond J. Taupier
-
Publication number: 20030064489Abstract: The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.Type: ApplicationFiled: March 12, 2001Publication date: April 3, 2003Inventors: Li Li, Muralidhara Padigaru, Corine A.M. Vernet, Elma R. Fernandes, Richard A. Shimkets, Steven K. Spaderna, Kumud Majumder
-
Publication number: 20030065140Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: April 3, 2001Publication date: April 3, 2003Inventors: Corine A.M. Vernet, Catherine E. Burgess, Elma R. Fernandes, Raymond J. Taupier, Kerry E. Quinn, Kimberly A. Spytek, Luca Rastelli, John L. Herrmann
-
Publication number: 20030050232Abstract: The invention provides polypeptides, designated herein as POLYX polypeptides, as well as polynucleotides encoding POLYX polypeptides, and antibodies that immunospecifically-bind to POLYX polypeptide or polynucleotide, or derivatives, variants, mutants, or fragments thereof. The invention additionally provides methods in which the POLYX polypeptide, polynucleotide, and antibody are used in the detection, prevention, and treatment of a broad range of pathological states.Type: ApplicationFiled: April 19, 2001Publication date: March 13, 2003Inventors: Raymond J. Taupier, Muralidhara Padigaru, Kimberly A. Spytek, Catherine E. Burgess, Corine A.M. Vernet, Elma R. Fernandes, Richard A. Shimkets, Xiaohong Liu, Kumud Majumder, Steven D. Colman, Bryan D. Zerhusen
-
Publication number: 20030017457Abstract: The present invention provides ORFX, a novel isolated polypeptide, as well as a polynucleotide encoding ORFX and antibodies that immunospecifically bind to ORFX or any derivative, variant, mutant, or fragment of the ORFX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the ORFX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to others uses.Type: ApplicationFiled: April 5, 2001Publication date: January 23, 2003Inventors: Elma R. Fernandes,, Corine A.M. Vernet, Vishnu S. Mishnu, Martin D. Leach, Richard A. Shimkets, Bryan D. Zerhusen, Ramesha Kekuda
-
Publication number: 20020155115Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.Type: ApplicationFiled: March 14, 2001Publication date: October 24, 2002Inventors: Corine A.M. Vernet, Elma R. Fernandes, Richard A. Shimkets, John L. Herrmann, Kumud Majumder, John R. MacDougall, Vishnu S. Mishra, Peter S. Mezes, Luca Rastelli